Hepatosplenic T cell lymphoma

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Hepatosplenic T cell lymphoma
ICD-O: 9716/3

WikiDoc Resources for Hepatosplenic T cell lymphoma

Articles

Most recent articles on Hepatosplenic T cell lymphoma

Most cited articles on Hepatosplenic T cell lymphoma

Review articles on Hepatosplenic T cell lymphoma

Articles on Hepatosplenic T cell lymphoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hepatosplenic T cell lymphoma

Images of Hepatosplenic T cell lymphoma

Photos of Hepatosplenic T cell lymphoma

Podcasts & MP3s on Hepatosplenic T cell lymphoma

Videos on Hepatosplenic T cell lymphoma

Evidence Based Medicine

Cochrane Collaboration on Hepatosplenic T cell lymphoma

Bandolier on Hepatosplenic T cell lymphoma

TRIP on Hepatosplenic T cell lymphoma

Clinical Trials

Ongoing Trials on Hepatosplenic T cell lymphoma at Clinical Trials.gov

Trial results on Hepatosplenic T cell lymphoma

Clinical Trials on Hepatosplenic T cell lymphoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hepatosplenic T cell lymphoma

NICE Guidance on Hepatosplenic T cell lymphoma

NHS PRODIGY Guidance

FDA on Hepatosplenic T cell lymphoma

CDC on Hepatosplenic T cell lymphoma

Books

Books on Hepatosplenic T cell lymphoma

News

Hepatosplenic T cell lymphoma in the news

Be alerted to news on Hepatosplenic T cell lymphoma

News trends on Hepatosplenic T cell lymphoma

Commentary

Blogs on Hepatosplenic T cell lymphoma

Definitions

Definitions of Hepatosplenic T cell lymphoma

Patient Resources / Community

Patient resources on Hepatosplenic T cell lymphoma

Discussion groups on Hepatosplenic T cell lymphoma

Patient Handouts on Hepatosplenic T cell lymphoma

Directions to Hospitals Treating Hepatosplenic T cell lymphoma

Risk calculators and risk factors for Hepatosplenic T cell lymphoma

Healthcare Provider Resources

Symptoms of Hepatosplenic T cell lymphoma

Causes & Risk Factors for Hepatosplenic T cell lymphoma

Diagnostic studies for Hepatosplenic T cell lymphoma

Treatment of Hepatosplenic T cell lymphoma

Continuing Medical Education (CME)

CME Programs on Hepatosplenic T cell lymphoma

International

Hepatosplenic T cell lymphoma en Espanol

Hepatosplenic T cell lymphoma en Francais

Business

Hepatosplenic T cell lymphoma in the Marketplace

Patents on Hepatosplenic T cell lymphoma

Experimental / Informatics

List of terms related to Hepatosplenic T cell lymphoma

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [7] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Synonyms

Hepatosplenic γδ T-cell lymphoma[1]

ICD-O Code

9716/3[1]

Definition

Hepatosplenic T-cell lymphoma is a systemic neoplasm comprised of medium-sized cytotoxic T-cells that show a significant sinusoidal infiltration in the liver, spleen, and bone marrow.[1]

Epidemiology

This lymphoma is rare, comprising less than 5% of all cases, and is most common in young adults and adolescents. A distinct male gender preference has been described.[2]

Clinical Features

Etiology

The cell of origin for this disease is an immature cytotoxic T-cell clonally expressing the γδ T-cell receptor. This disease is seen more often in immunosuppressed solid organ transplant recipients, an association that has led to the hypothesis that long-term immune stimulation in the setting of immunosuppression is the causative agent.[3][4]

Clinical Presentation

The typical clinical finding in a patient with hepatosplenic T-cell lymphoma is hepatosplenomegaly.[5]

Laboratory Findings

The constellation of thrombocytopenia, anemia, and leukocytosis is common in patients with hepatosplenic T-cell lymphoma.[2] The discovery of neoplastic cells in peripheral blood is often a finding late in the clinical course.[1]

Sites of Involvement

The spleen and liver are always involved, with bone marrow involvement frequently present. Nodal involvement is exceedingly rare.[2][1]

Morphology

The neoplastic cells in this disorder show a monotonous appearance, with a small amount of cytoplasm and inconspicuous nucleoli.[2]

Spleen and liver

This disease shows a distinct sinusoidal pattern of infiltration which spares the splenic white pulp and hepatic portal triads.[1]

Bone marrow

While the bone marrow is commonly involved, the detection of the neoplastic infiltrate may be difficult due to diffuse, interstitial pattern. Immunohistochemistry can aid in the detection of this lymphoma.[1]

Peripheral blood

Cells of a similar morphology observed in solid organs are observed in peripheral blood.[1]

Molecular Findings

Immunophenotype

The immunophenotype for hepatosplenic T-cell lymphoma is a post-thymic, immature T-cell.[1][2]

Status Antigens
Positive CD3, TCRδ1, TIA-1
Negative CD4, CD5, CD8

Genetic Findings

Clonal rearrangement of the γ gene of the T-cell receptor is the hallmark of this disease. A few cases have shown rearrangement of the T-cell receptor β gene.[1] Isochromosome 7q has been observed in all cases described so far, sometimes in conjunction with other chromosomal abnormalities such as trisomy 8.[6]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 [1] Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. (eds): World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. IARC Press: Lyon 2001
  2. 2.0 2.1 2.2 2.3 2.4 [2] Cooke CB, Krenacs L, Stetler-Stevenson M, Greiner TC, Raffeld M, Kingma DW, Abruzzo L, Frantz C, Kaviani M, Jaffe ES. "Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin." Blood. 1996 Dec 1;88(11):4265-74. PMID: 8943863
  3. [3] Ross CW, Schnitzer B, Sheldon S, Braun DK, Hanson CA. "Gamma/delta T-cell posttransplantation lymphoproliferative disorder primarily in the spleen." Am J Clin Pathol. 1994 Sep;102(3):310-5. PMID: 8085554
  4. [4] Macon WR, Levy NB, Kurtin PJ, Salhany KE, Elkhalifa MY, Casey TT, Craig FE, Vnencak-Jones CL, Gulley ML, Park JP, Cousar JB. "Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas." Am J Surg Pathol. 2001 Mar;25(3):285-96. PMID: 11224598
  5. [5] Farcet JP, Gaulard P, Marolleau JP, Le Couedic JP, Henni T, Gourdin MF, Divine M, Haioun C, Zafrani S, Goossens M, et al. "Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta." Blood. 1990 Jun 1;75(11):2213-9. PMID: 2140703
  6. [6] Alonsozana EL, Stamberg J, Kumar D, Jaffe ES, Medeiros LJ, Frantz C, Schiffer CA, O'Connell BA, Kerman S, Stass SA, Abruzzo LV. "Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma." Leukemia. 1997 Aug;11(8):1367-72. PMID: 9264394

Template:SIB

Template:WikiDoc Sources